Effects of N-acetylcysteine on matrix metalloproteinase-9 secretion and cell migration of human corneal epithelial cells

Eye (Basingstoke)

Volumn 26, Issue 8, 2012, Pages 1138-1144

  Ramaesh, T ^a,b   Ramaesh, K ^c   Riley, S C ^d   West, J D ^a   Dhillon, B ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

cornea; epithelium; healing; N acetylcysteine (NAC); recurrent corneal erosions (RCE)

Indexed keywords

ACETYLCYSTEINE; GELATIN; GELATINASE B;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORNEA EPITHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; EPITHELIUM CELL; GELATIN ZYMOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NONHUMAN; ZYMOGRAPHY;

EID: 84864846396     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.135     Document Type: Article

References (25)

1. Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol 2002; 47(3): 239-256.
2. Coleman CM, Hannush S, Covello SP, Smith FJ, Uitto J, McLean WH. A novel mutation in the helix termination motif of keratin K12 in a US family with Meesmann corneal dystrophy. Am J Ophthalmol 1999; 128(6): 687-691.
3. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21(1): 1-14.
4. Garrana RM, Zieske JD, Assouline M, Gipson IK. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest Ophthalmol Vis Sci 1999; 40(6): 1266-1270.
5. Sobrin L, Liu Z, Monroy DC, Solomon A, Selzer MG, Lokeshwar BL et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci 2000; 41(7): 1703-1709.
6. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999; 40(11): 2506-2512.
7. Brown SI, Tragakis MP, Pearce DB. Treatment of the alkali-burned cornea. Am J Ophthalmol 1972; 74(2): 316-320.
8. Haut J, Labrune P, Ullern M, Chermet M. New trial treatment of dry eye with acetylcysteine ophthalmic solution. Bull Soc Ophtalmol Fr 1977; 77(2): 165-167.
9. Petroutsos G, Guimaraes R, Giraud JP, Renard G, Pouliquen Y. Effect of acetylcysteine (Mucomyst) on epithelial wound healing. Ophthalmic Res 1982; 14(4): 241-248.
10. Sugar A, Waltman SR. Corneal toxicity of collagenase inhibitors. Invest Ophthalmol 1973; 12(10): 779-782.
11. Thermes F, Molon-Noblot S, Grove J. Effects of acetylcysteine on rabbit conjunctival and corneal surfaces. A scanning electron microscopy study. Invest Ophthalmol Vis Sci 1991; 32(11): 2958-2963.
12. Aldavood SJ, Behyar R, Sarchahi AA, Rad MA, Noroozian I, Ghamsari SM et al. Effect of acetylcysteine on experimental corneal wounds in dogs. Ophthalmic Res 2003; 35(6): 319-323.
13. Sarchahi AA, Maimandi A, Tafti AK, Amani M. Effects of acetylcysteine and dexamethasone on experimental corneal wounds in rabbits. Ophthalmic Res 2008; 40(1): 41-48.
14. Ramaesh T, Ramaesh K, Leask R, Springbett A, Riley SC, Dhillon B et al. Increased apoptosis and abnormal woundhealing responses in the heterozygous pax6/mouse cornea. Invest Ophthalmol Vis Sci 2006; 47(5): 1911-1917.
15. Riley SC, Leask R, Denison FC, Wisely K, Calder AA, Howe DC. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol 1999; 162(3): 351-359.
16. Hook CW, Brown SI, Iwanij W, Nakanishi I. Characterization and inhibition of corneal collagenase. Invest Ophthalmol 1971; 10(7): 496-503.
17. Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res 2001; 21(1A): 213-219.
18. Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 2003; 88(4): 1723-1729.
19. Beloosesky R, Gayle DA, Amidi F, Nunez SE, Babu J, Desai M et al. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol 2006; 194(1): 268-273.
20. Baldwin Jr AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
21. Li X, Stark GR. NF kappaB-dependent signaling pathways. Exp Hematol 2002; 30(4): 285-296.
22. Williamson J, Doig WM, Forrester JV, Tham MH, Wilson T, Whaley K et al. Management of the dry eye in Sjogren's syndrome. Br J Ophthalmol 1974; 58(9): 798-805.
23. Berman MB. Collagenase inhibitors: rationale for their use in treating corneal ulceration. Int Ophthalmol Clin 1975; 15(4): 49-66.
24. Fitton JH, Ziegelaar BW, Hicks CR, Clayton AB, Crawford GJ, Constable IJ et al. Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea. Cornea 1998; 17(1): 108-114.
25. Huo Y, Qiu WY, Pan Q, Yao YF, Xing K, Lou MF. Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing. Exp Eye Res 2009; 89(6): 876-886.